{"name":"Resolution Therapeutics Limited","slug":"resolution-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RTX001","genericName":"RTX001","slug":"rtx001","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"RTX001","genericName":"RTX001","slug":"rtx001","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE95cGc4R3RDMGx3NW1qSXE5dW94aVFJUnFWUFJQbHNMOVN5QUphTTRnSHlOQ1V3eE00R1h4a0h6VmlnY3o1MzN2VDg5Z0FuamhHYUNCaVk4bDd5dlFGSElPanZQbXpqQ3FteWRPRXVTeGRCUjdSYWEteHRHM0c?oc=5","date":"2026-04-08","type":"pipeline","source":"pharmaphorum","summary":"Advancing the case for cell and gene therapies - pharmaphorum","headline":"Advancing the case for cell and gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOV2RXUmsxUHJhNWNLMFRJOER5eE5kT1ljSDliX2tzNHZ6MmRqazdLdVUzRDZMWWpUNE1pS2dxM2lZUEtjeW5XQTkzdmtLcVdpYW9qTmJlQVR1cV84enBvazV6ZjJNTDVRVGVBbUlNcVdYZ2hPXzhnS0FPM1BEem9pZlU2ckRjVkJKSEV0ZXZDbUk4MjZ2YlVJ?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+ - openPR.com","headline":"Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPVXNtYW5VSlBUa1B4UWJJZlFTUFM1VVBzZE5fTXY0NWdRRHY4Ml9WZ1FlRERqLWlxamdGNjEzMnFYR25ibjBNd0pUVllKTWdxaC1Od1NrcHRHUEdqU0didTZBeXZZU1o3MEFWOVhPeU1sQUlTcjZOaWZyczRETlRwdzdTcGZRSUVHeEQ5UmtXVUJ0LW5ZcFg0YTNFTzRDalN5U25WU1BWLTJVWGRPaXlZS1BvOC1XSlg4R3R0aFpVeXNObnVnSEZ2UkhfWXI0NEM5dHJFUUUwdVJBUW4ydnZhaDZobjd1MjdYbFdFRA?oc=5","date":"2026-02-11","type":"pipeline","source":"Citeline News & Insights","summary":"Scrip Asks... What Does 2026 Hold For Biopharma? Part 5: AI And Operational Excellence - Citeline News & Insights","headline":"Scrip Asks... What Does 2026 Hold For Biopharma? Part 5: AI And Operational Excellence - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE92ODhZLVVWdGJabkVxTjlnUnI1LV9UNW5ZNjdSaWhoZ0d0LXNrWHY4OEZxd0Nsb1VmZGdxSVBtd0M4ZEF1UGxuaEs1Y081S3JmVkc0?oc=5","date":"2025-12-04","type":"regulatory","source":"FirstWord Pharma","summary":"FDA lifts partial hold on Vanda’s motion sickness drug following dispute resolution - FirstWord Pharma","headline":"FDA lifts partial hold on Vanda’s motion sickness drug following dispute resolution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZEVrSjY3QzdvRlhWclNPbXRnaUtaLU5zRzQyQnRmR0hra2pxalVBMUQtWFB3clhGcVJEZkFTUTF4VUQtTVRCbFJLLVREQmhoaExkejMzamotbE9xRDgtX0h4NHlLTHZLNzF1dUV1dWFiSVdnenBzUUNkLWhHTXBEajRsVUpOTWljSUtSZUJLZXJnb1Jsc0NSbUd2X2dYNWUzRjN2NUFINmQwNjZhSl9yQ1JCRQ?oc=5","date":"2025-11-14","type":"regulatory","source":"Fierce Pharma","summary":"FDA restricts Sarepta's gene therapy Elevidys after Duchenne patient deaths - Fierce Pharma","headline":"FDA restricts Sarepta's gene therapy Elevidys after Duchenne patient deaths","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNZnN3ajZuZF9peDlJeUVHUTJJd2hMdWF4Q3NQbUdDa21mdVhrd3pyNG9IV2Jva1RiOVdLV250amFhOG1YWUU2bTZJVmhKdnpSM2YxOWVZS1RhVmF6ekQzT0NnQnBMdkc0UmFpUkFDR25SaFpYLUlJem5TODZUekU2Rk1GRFFYZmdsNnVTT3hqX0tqXzM2M203TXNkdzdkeS1IMGJN?oc=5","date":"2025-10-01","type":"pipeline","source":"Yahoo Finance","summary":"Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration - Yahoo Finance","headline":"Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOaVNTNEVwMVczNWhSc1ZVU3VFaE95bG5idlk1OEJGVGZFVDF1SHhLS2Vqbk56a3JSMTZpN2ZQMTZVZ09aOXZzazhJZVFfTldmVlViZmYxZzdwcllaRFM3dUF5V1BTcGpSWEozX1Z6TDdQY21PeTV5QjdTdDdjSXlYMnE4VzlpOEdMbzVNZFhmcjdSaXA1bm1NWWJGa3o2bFhVUzNNdG8xelNQZDloRTBDcUtoWGttWVFx?oc=5","date":"2025-09-11","type":"pipeline","source":"PMLiVE","summary":"Resolution Therapeutics appoints Lucy Singah as CFO and Daniel Kennedy as CBO - PMLiVE","headline":"Resolution Therapeutics appoints Lucy Singah as CFO and Daniel Kennedy as CBO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOWUpXZ1BWUnJOSzl6ZDBCR3FHbnNVVDRpNzlhTUFRZU5qSDFmMjBXZGsybEw0bXBsTUF6dzJEQWxGR1Bta0R6dE1fWUpSVnJNQWpCOFVvWWtUVDhKTTc4NDNuV0RUWXhlVnFzVjNTYU5ZSUlJanFiWGJuRUpGZTlmM2RRUEg2d2VNWVE?oc=5","date":"2025-09-04","type":"trial","source":"Clinical Trials Arena","summary":"First subject dosed in Resolution’s liver cirrhosis therapy trial - Clinical Trials Arena","headline":"First subject dosed in Resolution’s liver cirrhosis therapy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQc2ttbGdKTTNHQzRnRGFrbjJXSzBzd01pbERCaDhtUmlmUEJyMGd4dTd4dE45WlBNNEhodXRiQzNkN2xQbmpsYzBYazB3ZHZPU2VlRXR3dXdSb0xodU9meUVhTTVPcUp3cGZwTmlNbHZPRDJadmhvTmVEcndhT2hmTjlldjVhWFUzMWRvUElCU3VncE5URV9ER2lwM19NaURiQmc?oc=5","date":"2025-09-03","type":"trial","source":"pharmatimes.com","summary":"Resolution Therapeutics doses first patient in EMERALD study of RTX001 - pharmatimes.com","headline":"Resolution Therapeutics doses first patient in EMERALD study of RTX001","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQMHdjNGRtV3h1aG5rbVI3QmNXWGxMTG9xek8yUjRBNENZZFNPcW5melM1c1N0cnVQR3BYYnNaZnkxbkE2OFFXU1ZkM3dwNjFCSUFlUUFaWHNTYWVmcktxdHlmTjdXNkVmai1JaHNlQ1ZjYU80QWtlcnlSc1JXa2tTdG9sSUFodHd1LTc0dVJHa3dxOFJRX0l4ZkVxeDVTUTItY0RYbkJDbkx3c2szQmlTUVktWQ?oc=5","date":"2025-07-15","type":"pipeline","source":"Pharmaceutical Commerce","summary":"New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform - Pharmaceutical Commerce","headline":"New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQZDdaeXZzYm93b2ZGbzVhaXpfVi1OcnliWVZnVHprbDhZQWVyc3ZvRFBTRlA5RURtUVYwRURQaVktdm9hc0lfUnlfUkxaSENianprUjJvZThzOF84S1ZmVGZzcXVlMUVmcVBZNWg3NXhXSXFMMWRma1VPS1BOcUFfaEJDSHpZTWVWT2R2VEZ4TkxxLWpQSzhObDk0ZlMzVXhLV0wxek5WbXN6ZWtSQVNvWFRyMjFEYUdFUlpHZDYzVjdTYjVyczI0Zk91OGtHOTAxX0x0Z0RjMWdUeU13MjVNN0ZoYnd5UU0?oc=5","date":"2025-07-11","type":"pipeline","source":"BioPharm International","summary":"Cellular Origins, Cell and Gene Therapy Catapult, and Resolution Therapeutics Form CGT Manufacturing Consortium - BioPharm International","headline":"Cellular Origins, Cell and Gene Therapy Catapult, and Resolution Therapeutics Form CGT Manufacturing Consortium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQZS1zN3MyX0pTUGJzcmdBWnIzd0s4YWlTYzRVOHZiNWJ5eGZpakVmcE5zbE1lQUJyR2pPd29kNkpGUjRFRE9MM1lGeHllTUs4ajRjT1lJNllDdVNibHRUTjVWYmU3N081T1ZfR3lYVlQwbHlRa2lkMVBwc2p5SG1nb0tfV253b0RWWjBOUThTcFROaThCeXBBU09YQk5DT0NZMUVlYmM3SkpOSkU0bHlIYlZPOXFhOS1GUzdlZVprV19uZWJXcTBlSDBhUy02OTkzWTY4MlM5S3ZESXF4Z0x5TXNkbXNVRUNCMTItMWRaczFxSFQyS2ZQQi1VbW8xXzZ0UE50QUM2d0k4cW8?oc=5","date":"2025-07-03","type":"pipeline","source":"globenewswire.com","summary":"Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team - globenewswire.com","headline":"Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}